Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease

Arthritis and Rheumatism

Volumn 52, Issue 4, 2005, Pages 1283-1286

  Lovell, Daniel J ^a,d   Bowyer, Suzanne L ^b   Solinger, Alan M ^c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMGEN INC   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; ETANERCEPT; HEMOGLOBIN; HYDROXYCHLOROQUINE SULFATE; INDOMETACIN; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 6; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; STEROID;

ADOLESCENT; ANAMNESIS; ANEMIA; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; CINCA SYNDROME; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; EYE INFLAMMATION; FEMALE; FEVER; HEADACHE; HUMAN; INFLAMMATORY DISEASE; LABORATORY TEST; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; RASH; SCHOOL CHILD;

ADOLESCENT; ANTIRHEUMATIC AGENTS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHILD; CHRONIC DISEASE; EXANTHEMA; FEMALE; HEMOGLOBINS; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; JOINTS; LEUKOCYTE COUNT; MALE; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; SYNDROME; TREATMENT OUTCOME;

EID: 17244381937     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20953     Document Type: Article

References (12)

1. Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL. The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003;15:61-9.
2. Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004;103:2809-15.
3. Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203.
4. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2004;348:2583-4.
5. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12.
6. Hawkins PN, Bybee A, Aganna E, McDermott MF. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease [letter]. Arthritis Rheum 2004;50:2708-9.
7. Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with, neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 2002;46:3340-8.
8. Calabro P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003;108:1930-2.
9. Prieur AM. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol 2001;19:103-6.
10. Huttenlocher A, Frieden IJ, Emery H. Neonatal onset multisystem inflammatory disease. J Rheumatol 1995;22:1171-3.
11. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002;20:S1-13.
12. Ramadori G, Christ B. Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999;19:141-55.